Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Galecto, Inc.

Equities

GLTO

US36322Q1076

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
0.6175 USD +0.72% Intraday chart for Galecto, Inc. -2.33% -14.24%
May. 01 Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab CI
Apr. 29 Galecto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GALECTO, INC. Stock Galecto, Inc.
 16.74M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. Charts Galecto, Inc.
  5. Sector Chart